Diabetes Biomarkers

A gene, molecule, or innate characteristic that aids in diagnosing disease is known as a molecular biomarker. HbA1c is regarded as a biomarker for diabetes that can be used to detect retinopathy, vascular disease, and nephropathy risk factors. These serve as prophylactic actions while the condition is subclinical. A quicker and more thorough understanding of the pathological process of diabetes can be achieved with the right use of the biomarker in the development of anti-diabetic medications.

  • Molecular biomarker
  • Retinopathy
  • Nephropathy risk factors

 

  • Molecular biomarker
  • Retinopathy
  • Nephropathy risk factors

Related Conference of Diabetes Biomarkers

May 08-09, 2025

5th European Endocrinology and Diabetes Congress

Madrid, Spain
May 19-20, 2025

5th World Congress on Endocrine and Diabetes

Rome, Italy
May 19-20, 2025

6th World Summit on Diabetes

Rome, Italy
June 04-05, 2025

4th World Congress on Diabetes and Pediatric Endocrinology

Edinburgh, Scotland
July 29-30, 2025

15th World Congress on Endocrinology and Diabetes

Paris, France
September 08-09, 2025

3rd World congress and Expo on Diabetes

Frankfurt, Germany
October 30-31, 2025

5th Annual Summit on Diabetes and Endocrinology

Paris, France
November 06-07, 2025

8th Annual Meeting on Diabetes and Endocrinology

Dubai, UAE
November 20-21, 2025

21st World Congress on Endocrinology & Diabetes

Paris, France
March 26-27, 2026

7th Global summit on Diabetes and Endocrinology

Amsterdam, Netherlands

Diabetes Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in